We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the potential ...

Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug ...

PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

EpiVax, Inc. proudly announces the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax's immunoinformatics team ...

The unveiling of the revamped logo, which combines vibrant blue and orange hues, is designed to reflect the seamless and dynamic nature of the services the utility provider offers to the nation’s ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend isn’t confined to Big Tech: It has been quietly happening in the ...

Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in hemp extract wellness products, is pleased to announce that the U.S. Food and Drug Administration (FDA) has ...

New drug shows promise in reversing memory loss for early Alzheimer's patients. ScienceDaily . Retrieved February 27, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250204141840.htm ...

Ms. Jinhua Zhang, Founder, Chairwoman, and CEO of IASO Bio, stated: "We are delighted that the New Drug Application for Equecabtagene Autoleucel has been officially accepted by the Hong Kong ...

The new drug combination reduced the risk of disease progression or death by 27%, with patients on the Calquence combination living an average of 66.4 months without their cancer getting worse ...

The FDA requested new and updated information and clarifications related to drug substance, drug product, manufacturing, and microbiology. The FDA did not express concern about the stability of the ...

The import license will be issued on the same day. (Performance Pledge) A notice of submission of supplementary documents for new drug application will be issued within 3 working days. (Performance ...